His primary areas of study are Immunology, Dendritic cell, Immune system, Immunotherapy and Antigen-presenting cell. The study incorporates disciplines such as Ex vivo and Cell biology in addition to Immunology. He has researched Dendritic cell in several fields, including Receptor and Lymph node.
His Immune system research is multidisciplinary, incorporating perspectives in Cancer, Melanoma and In vivo. The concepts of his Immunotherapy study are interwoven with issues in Clinical trial, IL-2 receptor, FOXP3 and Vaccination. His Antigen-presenting cell research includes elements of Toll-like receptor and Cancer immunotherapy.
His scientific interests lie mostly in Immunology, Immune system, Dendritic cell, Immunotherapy and Antigen. His biological study spans a wide range of topics, including Cancer and Melanoma. His Immune system research includes themes of Cytotoxic T cell, Cancer research and Ex vivo.
His Dendritic cell research incorporates themes from Acquired immune system, Antigen-presenting cell, Lymph node, Cell biology and In vivo. In his study, Immunogenicity is inextricably linked to Keyhole limpet hemocyanin, which falls within the broad field of Immunotherapy. His work is dedicated to discovering how Antigen, Antigen presentation are connected with Receptor and Internalization and other disciplines.
His primary areas of investigation include Immune system, Immunotherapy, Dendritic cell, Cancer research and Immunology. His study in Antigen extends to Immune system with its themes. His Immunotherapy study incorporates themes from Melanoma and Vaccination.
His Dendritic cell study combines topics from a wide range of disciplines, such as Myeloid, CD14, B cell and Cell biology. His Cell biology research is multidisciplinary, incorporating elements of Interferon and Antigen presentation. His Immunology research incorporates elements of Cell activation and Ex vivo.
His primary areas of study are Immune system, Immunotherapy, Cancer research, Antigen and Cell biology. In general Immune system study, his work on T cell and Tumor microenvironment often relates to the realm of Population, thereby connecting several areas of interest. His Immunotherapy study focuses on Cancer, Immunology and Internal medicine.
I. Jolanda M. de Vries is interested in Cancer immunotherapy, which is a field of Immunology. His Antigen course of study focuses on Myeloid and Prostate cancer and Progressive disease. In his research, I. Jolanda M. de Vries undertakes multidisciplinary study on Chemistry and Dendritic cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dendritic cell immunotherapy: mapping the way
Carl G Figdor;I Jolanda M de Vries;W Joost Lesterhuis;Cornelis J M Melief.
Nature Medicine (2004)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk.
Nature Biotechnology (2005)
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Paul J. Tacken;I. Jolanda M. de Vries;Ruurd Torensma;Carl G. Figdor.
Nature Reviews Immunology (2007)
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state
I. Jolanda M. de Vries;Daniëlle J. E. B. Krooshoop;Nicole M. Scharenborg;W. Joost Lesterhuis.
Cancer Research (2003)
The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.
Alessandra Cambi;Karlijn Gijzen;I. Jolanda M. de Vries;Ruurd Torensma.
European Journal of Immunology (2003)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
I. Jolanda M. de Vries;W. Joost Lesterhuis;Nicole M. Scharenborg;Linda P. H. Engelen.
Clinical Cancer Research (2003)
Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
Stanleyson V. Hato;Andrea Khong;I. Jolanda M. de Vries;W. Joost Lesterhuis.
Clinical Cancer Research (2014)
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
Jurjen Tel;Erik H.J.G. Aarntzen;Tetsuro Baba;Gerty Schreibelt.
Cancer Research (2013)
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production
Friederike Meyer-Wentrup;Daniel Benitez-Ribas;Paul J. Tacken;Cornelis J. A. Punt.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: